Leica Microsystems will provide worldwide support and service for all Viventis Microscopy products from now on. Credit: Shutterstock/Aris-Tect Group.

Netherlands-based Aiosyn has extended the use of its AI-powered quality control (QC) software for digital pathology by upgrading its algorithms, so it is compatible with more types of slide staining.

The company’s AiosynQC solution now works with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The software is able to automatically flags areas in the specimen. By identifying the most common artefacts in histology images, the software ensures that pathologists, technicians and researchers only use high-quality images.

According to Aiosyn, the QC solution streamlines workflows by identifying problematic slides before they reach the pathologist and reducing the need for manual checking.

IHC staining is a backbone technique of pathology laboratories, with it being critical in diagnostic work and clinical research.

Digital pathology is a quickly growing area in healthcare. Hospitals are implementing the technology to allow greater throughput of tissue diagnosis and quicker turnaround times of analysis. Major companies such as Fujifilm and Roche are also entering the growing market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Aiosyn chief technology officer David Tellez said: “Immunohistochemistry is an integral part of modern pathology practices, and we are excited to offer an AI-powered solution for QC compatible with IHC staining, empowering laboratories to further improve their pathology workflow.”

Separately in its portfolio, Aiosyn has also developed an AI tool to detect mitosis in whole slide images. By using deep learning, Mitosis-Breast can highlight mitotic figures in H&E slides. It is currently undergoing CE-mark certification under the EU in vitro medical device regulation.